Evaluation of Cardiags Trimod for Analysis of Cardiac Activity

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT05162599

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
CARDIAGS (from the registry)
Registry
  • NCT NCT05162599
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05162599. Allocation not applicable; no masking; primary purpose diagnostic. Start 2022-06-08 (actual); primary completion 2023-06-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Cardiags Trimod for Analysis of Cardiac Activity
Acronym
EVALTRIMOD
Condition
Murmur, Heart
Condition
Rhythm; Abnormal
Intervention (Device)
Diagnostic study, experimental evaluative cross-sectional study
Lead sponsor
CARDIAGS (class: industry)

Record details

Record id
cardio:ct-nct05162599
Content hash
53a039a4e53d538797085726ef8a1d76c1cebfd96eecce169bd1b2c24c4dad12